How to Avoid the Worst Fees in America
Nothing gets under the skin of a savvy consumer like unwarranted and unwanted fees.
The Web site GoBankingRates.com has put together a list of the “31 Worst Fees in America,” listing some of the most egregious fees out there, as well as tips on two avoid them. The list includes 11 banking fees, 10 travel fees, and handful of fees from other categories such as health care and cell phones.
“At the bank, while traveling, or just when going about your daily business, fees are on the rise in seemingly all industries—and not just in quantity, but in price,” writes author Paul Sisolak. “Many times, they’re so well obscured that you end up paying fees without realizing it.”
The good news is that in most cases, there’s an easy fix for the fees: Avoid bank teller fees, for example, by using remote deposit and ATMs; and steer clear of ATM fees by using your bank’s app to find the nearest in-network machine.
Related: 10 Infuriating Consumer Fees to Stop Paying Now
While bank fees may be rising, the institutions are getting better about being transparent in disclosing them. More than 60 percent of the banks reviewed last week by The Pew Charitable Trusts have adopted a summary disclosure box of terms and fees that meets the organization’s standards, up from just 25 percent in 2013.
When it comes to avoiding fees while traveling, pack light to avoid overweight bag charges and call ahead of time to get a sense of Wi-Fi and other hotel/resort fees.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
